IMPLANT SITE HYPERAESTHESIA

IMPLANT SITE HYPERAESTHESIA was reported 10 times

IMPLANT SITE HYPERAESTHESIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progestin [EPC] 9 0.0000
1 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000